The blockbuster GLP-1 drugs that reshaped the treatment of diabetes and obesity may help prevent multiple substance use disorders — and reduce their tragic outcomes, a large new study found.

Sell on Novo Nordisk A/S: slowing growth, downgraded 2025 guidance, rising GLP-1 competition, pricing/patent risks, limited ...

Kroger said it is now stocking Eli Lilly's injection pen version of the weight-loss drug Zepbound, and will allow self-pay customers to use Lilly's savings card at its retail pharmacies. The ...

BOOTS is giving a 25 per cent discount on weight loss jabs to slimmers who start jogging or going to the gym. People on Wegovy or Mounjaro could save up to £1,000 a year by showing they’re ...

AS I nervously uploaded a photo from my phone onto a pharmacy website, I took a deep breath before hitting send. As a size 8, ...

The UK is one of the heaviest nations in Europe now with 64 per cent of the population overweight or obese, and one in four ...

As an increasing number of patients come forward with claims that their vision has been permanently impacted by weight loss jabs, eye experts have issued a vital statistical warni ...

The weight-loss jab Wegovy may carry the highest risk of sudden sight loss compared to other semaglutide drugs such as ...

NAION is often referred to as an ‘eye stroke’, it causes sudden, painless vision loss - usually in one eye, but sometimes in both eyes.

The weight-loss jab Wegovy may carry the highest risk of sudden sight loss compared to other semaglutide drugs such as Ozempic, according to new analysis. The odds of having a so-called “eye stroke” ...

The weight-loss jab Wegovy may carry the highest risk of sudden sight loss compared to other semaglutide drugs such as Ozempic, according to new analysis. The odds of having a so-called “eye stroke” ...

NAION (Non-Arteritic Anterior Ischemic Optic Neuropathy) officially describes vision loss caused by reduced blood flow to the optic nerve ...